Description

Legend Biotech is seeking a Finance & Accounting Intern as part of the Finance team based in Somerset, NJ.

Role Overview

Legend Biotech is seeking a Finance & Accounting Intern to join our Accounting Team for our 2026 Summer Internship Program, which will run from June 1st, 2026, to August 14th, 2026.

Key Responsibilities

Intern will rotate on a weekly or bi-weekly basis to the different Finance & Accounting groups covering:

• US Accounting.
• RoW (Ireland, Belgium, Cayman) Accounting.
• Accounts Payable.
• External Reporting & Technical Accounting.
• Internal Audit.
• Master Data Governance.

Key responsibilities will include, but are not limited to, supporting the following activities:

• Month-end close of accounting books including all month-end activities like accruals, account reconciliations, processing invoices, manual journal entries, etc.
• Post-close financial analysis of actual results.
• Ingesting and processing third-party and intercompany invoices.
• Consolidation of quarter-end financial statements and disclosures and preparation of external SEC filings.
• Technical Accounting research and analyses of business transactions and events.
• Internal audits including operational audits against company policies and compliance and exposure to internal audit support of the external audit.
• Master data governance within ERP systems for Finance & Accounting.
• Leveraging automation, technology, and GenAI for process efficiency and enhanced task performance.

Decision Making

• Support decision-making by analyzing financial data and summarizing key insights.

Requirements

• In process bachelor's or master's degree of accounting, finance, or professional business degree.
• Junior year or higher for undergraduate students) with all introduction coursework completed in fundamental accounting principles (ideally intermediate accounting), Finance, and/or Economics.
• Interest in becoming a CPA or FP&A professional.
• Basic skills with Microsoft 365 applications, especially excel.
• Familiarity with automation concepts and GenAI tools.
• Strong ownership of task completion.
• Strong analytical and problem-solving skills.

#Li-BG1

#Li-Hybrid

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.

Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.

Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.

EEO Statement

It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.

Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.

For information related to our privacy notice, please review: Legend Biotech Privacy Notice .